Forsedeno^®

International nonproprietary name

Denosumab

Description

The drug is intended for the treatment of osteoporosis. It helps strengthen bones and reduces the risk of fractures, improving the patients' quality of life.

Therapeutic areas

For the treatment of osteoporosis in postmenopausal women, osteoporosis in men at increased risk of fracture, and to prevent bone loss in men with prostate cancer after surgery or hormone therapy. It is used for bone mass loss associated with long-term glucocorticosteroid therapy in adult patients at increased risk of fracture.